Pharmacy & Therapeutics - May 2008 - (Page 254) STATEMENT OF PURPOSE Pharmacy and Therapeutics P&T® provides pharmacy and therapeutics committee members with the latest information to help them manage their formularies and establish medication-related policies. Articles are authored by experts in the field and undergo a thorough peer review. A crucial aspect of P&T’s® mission is to highlight research and data on drug utilization, prescribing, and adverse drug reactions in order to facilitate the best possible outcomes for patients. Editorial content targets P&T committee members across the health care spectrum, including those in hospitals, health systems, and managed care organizations as well as individuals who are state and federal formulary decision makers. Articles address cost-containment strategies, critical drug appraisals, drug utilization evaluations, and disease management. P&T® has a circulation of approximately 50,000 readers. EDITORIAL Editor: Sonja Sherritze (267) 685-2779 ssherritze@medimedia.com Associate Editor: Carol Robins (267) 685-2778 crobins@medimedia.com News Writer: Janet Dyer ART Design Director: Philip Denlinger Trademark: P&T is a registered trademark of MediMedia USA, Inc. Publisher: P&T® is a peer-reviewed journal for managed care and hospital formulary management (ISSN 1052-1372) (GST #128741063) (IPM #0608025) and is published monthly by MediMedia USA, Inc., with business offices at 780 Township Line Road, Yardley, PA 19067; telephone: (267) 685-2788; fax: (267) 685-2966. Copyright: Copyright 2008 by MediMedia USA, Inc. All rights reserved under the United States, International, and Pan-American Copyright Conventions. No part of this publication may be reproduced, stored in a retrieval system, photocopied, or transmitted in any form or by any means, mechanical, electronic, or otherwise, without the prior written permission of MediMedia USA, Inc. The copyright law of the United States governs the making of photocopies or other reproductions of copyrighted material. Opinions: The articles in P&T® are reviewed by appropriate members of the editorial board and/or other qualified experts. The opinions are those of the authors and are not those of the publisher, editor, editorial board, or institutions that employ the authors. Clinical judgment must guide each clinician in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this publication may reflect the professional literature and other clinical sources or the clinical experience of the authors and might not be the same as indicated on the approved package insert. Please consult the complete prescribing information for any products mentioned in this publication. MediMedia USA, Inc., assumes no liability for the information published herein. Reprints: Contact Lisa Gardineer; telephone: (267) 685-2789; fax: (267) 685-2966. Subscriptions: Price—Individuals or Institutions: U.S., $85; U.S. Students/Residents/Nurses, $30; Outside U.S.: $120. Single copies: $12 per copy U.S.; $22 per copy outside U.S. Inquiries about paid subscriptions: Lisa Gardineer, telephone (267) 685-2789; e-mail: lgardineer@medimedia.com. POSTMASTER: Send address changes to P&T® Journal, 2900 New Rodgers Road, Bristol, PA 19007. Periodicals postage paid at Morrisville, PA, and at additional mailing offices. ® PUBLISHING Group Publisher: Timothy P. Search, RPh (267) 685-2781 tsearch@medimedia.com Director, New Product Development: Timothy J. Stezzi (267) 685-2780 tstezzi@medimedia.com Eastern Sales Manager: Scott MacDonald (267) 685-2787 smacdonald@medimedia.com Senior Account Manager: Kenneth D. Watkins, III (973) 785-4839 kwatkins@watkinsrepgroup.com Circulation Manager: Jacquelyn Ott Circulation Inquiries: Lisa Gardineer (267) 685-2789 P&T@icnfull.com Director of Production Services: Waneta Peart (267) 685-2782 wpeart@medimedia.com Office fax: (267) 685-2966 P&T® is abstracted or indexed in the following reference sources: CINAHL (in print and online), EMBASE (in print and online), and International Pharmaceutical Abstracts. 254 P&T® • May 2008 • Vol. 33 No. 5
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.